3月9日，2026年首批港股通标的调整落地，42股调入、25股调出，其中大健康板块独占30%权重。这场资本“换血"瞬间撕裂板块情绪——科济药业-B盘中飙涨40%，轻松健康、维立志博-B跟涨15%以上；而调出阵营里，方舟健客暴跌30%，一脉阳光重挫26.5%，药师帮、艾迪康控股跌幅均超15%。同一政策窗口，生与死的分化不过一线之隔。但这并非简单的“调入即生、调出即死"。派格生物医药-B、长风药业、...
Source Link3月9日，2026年首批港股通标的调整落地，42股调入、25股调出，其中大健康板块独占30%权重。这场资本“换血"瞬间撕裂板块情绪——科济药业-B盘中飙涨40%，轻松健康、维立志博-B跟涨15%以上；而调出阵营里，方舟健客暴跌30%，一脉阳光重挫26.5%，药师帮、艾迪康控股跌幅均超15%。同一政策窗口，生与死的分化不过一线之隔。但这并非简单的“调入即生、调出即死"。派格生物医药-B、长风药业、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.